ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.
Rocket Pharmaceuticals Inc

Rocket Pharmaceuticals Inc (RCKT)

22.50
0.54
(2.46%)
Closed July 14 4:00PM
22.50
0.01
(0.04%)
After Hours: 7:05PM

Rocket Pharmaceuticals Inc Financial Summary

The current RCKT market cap is 2.04B. The company's latest EPS is USD -2.7053 and P/E is -0.03.

Quarter End Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024
USD ($)USD ($)USD ($)USD ($)USD ($)
Total Revenue 00000
Operating Income -62.19M-68.76M-65.43M-63.28M-67.38M
Net Income -58.34M-65.7M-61.9M-59.66M-62.05M
Year End December 30 2023 20192020202120222023
USD ($)USD ($)USD ($)USD ($)USD ($)
Total Revenue 00000
Operating Income -76.15M-134.3M-167.25M-224.34M-259.66M
Net Income -77.27M-139.7M-169.07M-221.86M-245.6M
Quarter End Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024
USD ($)USD ($)USD ($)USD ($)USD ($)
Total Assets 514.76M461.78M598.76M566.34M499.44M
Total Liabilities 55.88M58.81M57.68M73.77M57.94M
Total Equity 458.88M402.97M541.09M492.57M441.5M
Year End December 30 2023 20192020202120222023
USD ($)USD ($)USD ($)USD ($)USD ($)
Total Assets 372.12M590.82M497.02M551.81M566.34M
Total Liabilities 64.82M87.31M42.3M62.12M73.77M
Total Equity 307.3M503.52M454.72M489.69M492.57M
Quarter End Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024
USD ($)USD ($)USD ($)USD ($)USD ($)
Operating -57.56M-108.43M-165.58M-194.92M-56.86M
Investing -36.72M-5.52M42.74M-98.07M35.03M
Financing 18.34M18.53M208.01M208.4M1.18M
Year End December 30 2023 20192020202120222023
USD ($)USD ($)USD ($)USD ($)USD ($)
Operating -64.66M-74.64M-121.16M-178.14M-194.92M
Investing -39.01M-96.59M18.85M-69.33M-98.07M
Financing 177.79M282.99M37.68M155.29M208.4M
Market Cap 2.04B
Price to Earnings Ratio -0.03
Price to Sales Ratio 0
Price to Cash Ratio 0.13
Price to Book Ratio 0.01
Dividend Yield -

Share Statistics

Shares Outstanding 90.78M
Average Volume (1 week) 704.58k
Average Volume (1 Month) 1.13M
52 Week Change 13.69%
52 Week High 32.525
52 Week Low 14.89
Spread (Intraday) 2.46 (10.79%)

Company Info

Company Name Rocket Pharmaceuticals Inc
Address 300 delaware avenue
wilmington, delaware 19801
Website https://www.rocketpharma.com
Industry pharmaceutical preparations (2834)

Your Recent History

Delayed Upgrade Clock